The weight loss drug market is exploding, with new products entering the scene to compete with big names like Ozempic. It is ...

Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Therapist Debby Parker tried to lose weight for years without success. Then she discovered an online weight management ...

Her departure comes as the snacks maker faces challenges including higher cocoa costs, inflation that has curtailed product ...

Trusted by U.S. Physicians and Pharmacies and Available Nationwide. Take Control of Your Weight Loss Journey: How Does GLP-1 ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

Jonathan Van Ness has admitted to using weight-loss medication and feels back in 'control' of eating disorder.

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...

Consumers who take GLP-1 drugs might switch what they eat, but they largely spend the same amount of money on CPG food and ...

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...